Live Breaking News & Updates on Karl Mahler|Page 7
Stay updated with breaking news from Karl mahler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Results to be presented for the first time show mosunetuzumab induces high and durable complete response rates in people with follicular lymphoma who have received two or more prior therapies –– New efficacy data from Genentech’s portfolio of cancer immunotherapies demonstrate potential of bispecific antibodies to. ....
After 2.5 years median follow-up, pre-planned exploratory analyses in the PD-L1-high population show clinically meaningful results, with overall survival not yet reached and continued progression-free ....
EMA's CHMP recommended the approval yesterdayApproval based on results from four phase III studies in over 5,500 patientsActemra/RoActemra has also been provisionally approved in Australia for the treatment ....
Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase III studiesThe European Commission is expected to make a final decision regarding approval ....
The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient ....